JAYME KUNKEL: Open Payments
NPI 1700485943 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 37 payments from 19 companies in 2025. Trend: 2023 $1,134 · 2024 $1,133 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $270 |
| SHIELD THERAPEUTICS INC | 2 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Radius Health, Inc. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| PFIZER INC. | 3 | $51 |
| Lilly USA, LLC | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| ABBVIE INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: Wegovy, ACCRUFER, LEQVIO, Tymlos, TRINTELLIX, MOUNJARO, Ozempic, Auvelity.
Industry payments across VA — which companies pay providers there.
